These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30871403)

  • 1. DNA methylation changes associated with Parkinson's disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood.
    Henderson-Smith A; Fisch KM; Hua J; Liu G; Ricciardelli E; Jepsen K; Huentelman M; Stalberg G; Edland SD; Scherzer CR; Dunckley T; Desplats P
    Epigenetics; 2019 Apr; 14(4):365-382. PubMed ID: 30871403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson's Disease.
    Chuang YH; Lu AT; Paul KC; Folle AD; Bronstein JM; Bordelon Y; Horvath S; Ritz B
    J Parkinsons Dis; 2019; 9(2):389-400. PubMed ID: 30958317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson's disease patients.
    Fernández-Santiago R; Merkel A; Castellano G; Heath S; Raya Á; Tolosa E; Martí MJ; Consiglio A; Ezquerra M
    Clin Epigenetics; 2019 Jul; 11(1):108. PubMed ID: 31337434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.
    Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD
    Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson's Disease.
    Yazar V; Dawson VL; Dawson TM; Kang SU
    J Parkinsons Dis; 2023; 13(2):145-164. PubMed ID: 36710687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease.
    Gonzalez-Latapi P; Bustos B; Dong S; Lubbe S; Simuni T; Krainc D
    Ann Neurol; 2024 Jun; 95(6):1162-1172. PubMed ID: 38563317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation of the 5'-UTR DAT 1 gene in Parkinson's disease patients.
    Rubino A; D'Addario C; Di Bartolomeo M; Michele Salamone E; Locuratolo N; Fattapposta F; Vanacore N; Pascale E
    Acta Neurol Scand; 2020 Sep; 142(3):275-280. PubMed ID: 32415851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
    Jakubowski JL; Labrie V
    J Parkinsons Dis; 2017; 7(1):1-12. PubMed ID: 27792016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease is associated with DNA methylation levels in human blood and saliva.
    Chuang YH; Paul KC; Bronstein JM; Bordelon Y; Horvath S; Ritz B
    Genome Med; 2017 Aug; 9(1):76. PubMed ID: 28851441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenome-wide association study of DNA methylation in panic disorder.
    Shimada-Sugimoto M; Otowa T; Miyagawa T; Umekage T; Kawamura Y; Bundo M; Iwamoto K; Tochigi M; Kasai K; Kaiya H; Tanii H; Okazaki Y; Tokunaga K; Sasaki T
    Clin Epigenetics; 2017; 9():6. PubMed ID: 28149334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential blood biomarkers for Parkinson's disease by gene expression and DNA methylation data integration analysis.
    Wang C; Chen L; Yang Y; Zhang M; Wong G
    Clin Epigenetics; 2019 Feb; 11(1):24. PubMed ID: 30744671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson's disease revealed different epigenetic patterns in peripheral blood mononuclear cells.
    Kaut O; Schmitt I; Tost J; Busato F; Liu Y; Hofmann P; Witt SH; Rietschel M; Fröhlich H; Wüllner U
    Neurogenetics; 2017 Jan; 18(1):7-22. PubMed ID: 27709425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro.
    Schmitt I; Kaut O; Khazneh H; deBoni L; Ahmad A; Berg D; Klein C; Fröhlich H; Wüllner U
    Mov Disord; 2015 Nov; 30(13):1794-801. PubMed ID: 26173746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson's disease.
    Vallerga CL; Zhang F; Fowdar J; McRae AF; Qi T; Nabais MF; Zhang Q; Kassam I; Henders AK; Wallace L; Montgomery G; Chuang YH; Horvath S; Ritz B; Halliday G; Hickie I; Kwok JB; Pearson J; Pitcher T; Kennedy M; Bentley SR; Silburn PA; Yang J; Wray NR; Lewis SJG; Anderson T; Dalrymple-Alford J; Mellick GD; Visscher PM; Gratten J
    Nat Commun; 2020 Mar; 11(1):1238. PubMed ID: 32144264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA methylome in panic disorder: a case-control and longitudinal psychotherapy-epigenetic study.
    Ziegler C; Grundner-Culemann F; Schiele MA; Schlosser P; Kollert L; Mahr M; Gajewska A; Lesch KP; Deckert J; Köttgen A; Domschke K
    Transl Psychiatry; 2019 Nov; 9(1):314. PubMed ID: 31754096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenome-wide association study for Parkinson's disease.
    Moore K; McKnight AJ; Craig D; O'Neill F
    Neuromolecular Med; 2014 Dec; 16(4):845-55. PubMed ID: 25304910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation in childhood asthma: an epigenome-wide meta-analysis.
    Xu CJ; Söderhäll C; Bustamante M; Baïz N; Gruzieva O; Gehring U; Mason D; Chatzi L; Basterrechea M; Llop S; Torrent M; Forastiere F; Fantini MP; Carlsen KCL; Haahtela T; Morin A; Kerkhof M; Merid SK; van Rijkom B; Jankipersadsing SA; Bonder MJ; Ballereau S; Vermeulen CJ; Aguirre-Gamboa R; de Jongste JC; Smit HA; Kumar A; Pershagen G; Guerra S; Garcia-Aymerich J; Greco D; Reinius L; McEachan RRC; Azad R; Hovland V; Mowinckel P; Alenius H; Fyhrquist N; Lemonnier N; Pellet J; Auffray C; ; van der Vlies P; van Diemen CC; Li Y; Wijmenga C; Netea MG; Moffatt MF; Cookson WOCM; Anto JM; Bousquet J; Laatikainen T; Laprise C; Carlsen KH; Gori D; Porta D; Iñiguez C; Bilbao JR; Kogevinas M; Wright J; Brunekreef B; Kere J; Nawijn MC; Annesi-Maesano I; Sunyer J; Melén E; Koppelman GH
    Lancet Respir Med; 2018 May; 6(5):379-388. PubMed ID: 29496485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DRD2 methylation to differentiate dementia with Lewy bodies from Parkinson's disease.
    Ozaki Y; Yoshino Y; Yamazaki K; Ochi S; Iga JI; Nagai M; Nomoto M; Ueno SI
    Acta Neurol Scand; 2020 Feb; 141(2):177-182. PubMed ID: 31659741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in Parkinson's disease.
    Wüllner U; Kaut O; deBoni L; Piston D; Schmitt I
    J Neurochem; 2016 Oct; 139 Suppl 1():108-120. PubMed ID: 27120258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imputation of DNA Methylation Levels in the Brain Implicates a Risk Factor for Parkinson's Disease.
    Rawlik K; Rowlatt A; Tenesa A
    Genetics; 2016 Oct; 204(2):771-781. PubMed ID: 27466229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.